An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
California Judge Rules That Teva Did Not Cause a Public Nuisance or Make False or Misleading Statements About Opioids
Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Teva Pharmaceutical Industries Limited has achieved a legal victory as Judge Peter Wilson of the Superior Court in California ruled that Teva did not cause a public nuisance regarding opioid marketing in Orange County, Los Angeles County, Santa Clara County, and Oakland. The court also found that Teva did not engage in false or misleading advertising practices. Teva emphasizes the need for comprehensive settlements to support those affected by opioid addiction, while it remains committed to providing affordable medicines globally.
Positive
Legal victory in California courts confirming no public nuisance and no false marketing claims regarding opioids.
Negative
Ongoing opioid litigation may still pose risks despite current legal win.
PARSIPPANY, N.J.--(BUSINESS WIRE)--
Today, Orange County, California, Superior Court Judge Peter Wilson issued a decision finding that Teva did not cause a public nuisance in Orange County, Los Angeles County, Santa Clara County and the City of Oakland and that Teva did not make any false or misleading statements in connection with marketing prescription opioids in California.
While we are pleased that the Court in California made this determination, a clear win for the many patients in the US who suffer from opioid addiction will only come when comprehensive settlements are finalized and resources are made available to all who need them. Teva continues to pursue a national settlement framework as well as to support the business of Teva, which remains dedicated to providing uninterrupted access to affordable medicines throughout the world.